Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nephromics
- Ownership
- Private
- Development stage
- Other
01
Overview
Nephromics licensed preeclampsia biomarker rights (including PlGF) and sublicensed them to major diagnostic companies, which then developed and commercialized preeclampsia risk-assessment and monitoring assays; the company itself is not running interventional clinical trials but supports clinical validation through partners’ studies.
- Therapeutic areas
- Women's Health
- Modalities
- Device
- Industry
- Protein Biomarker Diagnostics
02
Partnerships
Beckman Coulter (rights and royalty agreement for preeclampsia test; Beckman later bought out its royalty obligations and obtained full rights to the Nephromics preeclampsia test)Thermo Fisher Scientific (acquired all rights for a preeclampsia biomarker from Nephromics, including exclusive PlGF diagnostic license)Multiple unnamed major diagnostic companies (Nephromics sublicensed its preeclampsia diagnostic IP to several major diagnostics players)
Beyond the preview
Go deeper on Nephromics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nephromics.